Orlando Magic · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 18.2 | 11.3 | 11.0 | 2.3 | 24.7 | 0.7 | 0.7 | 0.7 | 4.7 | 6.7 |
| 70.0% |
| 0.0 |
| 0.0 |
| 0.0% |
| 2.0 |
| 2.3 |
| 85.7% |
| Last 5 | 5 | 19.0 | 9.8 | 9.0 | 1.8 | 20.6 | 0.8 | 1.4 | 1.2 | 4.2 | 6.0 | 70.0% | 0.0 | 0.0 | 0.0% | 1.4 | 1.8 | 77.8% |
| Last 10 | 10 | 16.0 | 7.0 | 6.2 | 1.3 | 14.5 | 0.5 | 0.9 | 1.4 | 2.7 | 4.3 | 62.8% | 0.0 | 0.0 | 0.0% | 1.6 | 2.0 | 80.0% |
| Last 20 | 20 | 13.5 | 5.8 | 5.0 | 1.6 | 12.4 | 0.3 | 0.5 | 0.9 | 2.2 | 3.5 | 65.2% | 0.0 | 0.1 | 0.0% | 1.3 | 1.9 | 70.3% |
| Season | 64 | 15.2 | 5.9 | 5.0 | 1.3 | 12.2 | 0.6 | 1.0 | 0.7 | 2.3 | 3.3 | 70.1% | 0.0 | 0.2 | 18.2% | 1.1 | 1.5 | 71.1% |
high offensive rebounding, high rim finishing off the ball, high contested shots per minute, low off-ball shooting
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | ORL @ BOS | L | 16.4 | 5 | 7 | 1 | 0 | 0 | 1 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -1.0 |
| 2026-04-10 | ORL @ CHI | W | 16.6 | 15 | 11 | 0 | 1 | 2 | 0 | 6 | 7 | 85.7% | 0 | 0 | 0.0% | 3 | 3 | 100.0% | 4.0 |
| 2026-04-08 | ORL vs. MIN | W | 21.7 | 14 | 15 | 6 | 1 | 0 | 1 | 6 | 11 | 54.5% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 21.0 |
| 2026-04-06 | ORL vs. DET | W | 24.2 | 9 | 4 | 1 | 1 | 3 | 2 | 4 | 6 | 66.7% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -12.0 |
| 2026-04-05 | ORL @ NOP | W | 16.3 | 6 | 8 | 1 | 1 | 2 | 2 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 9.0 |
| 2026-04-03 | ORL @ DAL | W | 12.2 | 2 | 4 | 2 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 5.0 |
| 2026-04-01 | ORL vs. ATL | L | 15.4 | 4 | 5 | 1 | 0 | 2 | 3 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-03-31 | ORL vs. PHX | W | 14.0 | 3 | 2 | 1 | 0 | 0 | 1 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 3 | 4 | 75.0% | -3.0 |
| 2026-03-29 | ORL @ TOR | L | 10.2 | 6 | 4 | 0 | 0 | 0 | 2 | 2 | 5 | 40.0% | 0 | 0 | 0.0% | 2 | 3 | 66.7% | -22.0 |
| 2026-03-26 | ORL vs. SAC | W | 12.6 | 6 | 2 | 0 | 1 | 0 | 2 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 4.0 |
| 2026-03-24 | ORL @ CLE | L | 13.6 | 4 | 2 | 3 | 1 | 0 | 0 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2026-03-23 | ORL vs. IND | L | 19.9 | 6 | 7 | 4 | 0 | 0 | 2 | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 4 | 6 | 66.7% | 4.0 |
| 2026-03-21 | ORL vs. LAL | L | 18.1 | 9 | 7 | 5 | 0 | 0 | 2 | 3 | 3 | 100.0% | 0 | 0 | 0.0% | 3 | 4 | 75.0% | 9.0 |
| 2026-03-19 | ORL @ CHA | L | 18.9 | 4 | 2 | 1 | 1 | 1 | 0 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -17.0 |
| 2026-03-17 | ORL vs. OKC | L | 5.9 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -1.0 |
| 2026-03-16 | ORL @ ATL | L | 5.5 | 4 | 3 | 1 | 0 | 0 | 0 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 8.0 |
| 2026-03-12 | ORL vs. WAS | W | 4.1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2026-03-08 | ORL @ MIL | W | 8.5 | 7 | 5 | 2 | 0 | 0 | 1 | 3 | 4 | 75.0% | 0 | 1 | 0.0% | 1 | 4 | 25.0% | 8.0 |
| 2026-03-07 | ORL @ MIN | W | 3.8 | 4 | 4 | 1 | 0 | 0 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 5.0 |
| 2026-03-05 | ORL vs. DAL | W | 12.1 | 8 | 4 | 2 | 0 | 0 | 0 | 4 | 4 | 100.0% | 0 | 0 | 0.0% | 0 | 1 | 0.0% | 3.0 |
| 2026-03-03 | ORL vs. WAS | W | 21.5 | 9 | 6 | 2 | 0 | 1 | 1 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 5 | 8 | 62.5% | 8.0 |
| 2026-02-21 | ORL @ PHX | L | 8.7 | 4 | 3 | 0 | 0 | 1 | 1 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -9.0 |
| 2026-02-05 | ORL vs. BKN | W | 6.0 | 6 | 1 | 0 | 0 | 1 | 0 | 3 | 3 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -6.0 |
| 2026-02-01 | ORL @ SAS | L | 8.6 | 4 | 2 | 0 | 0 | 0 | 0 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 11.0 |
| 2026-01-24 | ORL vs. CLE | L | 5.3 | 2 | 6 | 0 | 0 | 0 | 0 | 1 | 4 | 25.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 2.0 |
| 2026-01-22 | ORL vs. CHA | L | 11.5 | 0 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -11.0 |
| 2026-01-18 | ORL @ MEM | L | 15.0 | 9 | 6 | 1 | 0 | 2 | 2 | 4 | 4 | 100.0% | 0 | 0 | 0.0% | 1 | 1 | 100.0% | -2.0 |
| 2026-01-15 | ORL @ MEM | W | 12.4 | 5 | 3 | 1 | 0 | 0 | 0 | 2 | 5 | 40.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -10.0 |
| 2026-01-11 | ORL vs. NOP | W | 32.1 | 14 | 13 | 1 | 3 | 2 | 0 | 7 | 10 | 70.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 23.0 |
| 2026-01-09 | ORL vs. PHI | L | 11.9 | 2 | 3 | 0 | 1 | 2 | 0 | 1 | 3 | 33.3% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -13.0 |
| 2026-01-07 | ORL @ BKN | W | 13.5 | 6 | 10 | 1 | 3 | 0 | 0 | 3 | 5 | 60.0% | 0 | 0 | 0.0% | 0 | 2 | 0.0% | 5.0 |
| 2026-01-06 | ORL @ WAS | L | 20.2 | 10 | 5 | 0 | 0 | 0 | 0 | 5 | 7 | 71.4% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -7.0 |
| 2026-01-04 | ORL vs. IND | W | 16.5 | 2 | 2 | 0 | 0 | 0 | 1 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2026-01-02 | ORL @ CHI | L | 16.2 | 5 | 4 | 3 | 2 | 2 | 0 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -14.0 |
| 2025-12-31 | ORL @ IND | W | 19.1 | 14 | 9 | 3 | 0 | 0 | 2 | 6 | 7 | 85.7% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 3.0 |
| 2025-12-29 | ORL @ TOR | L | 15.8 | 2 | 5 | 0 | 0 | 2 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 1 | 0.0% | -5.0 |
| 2025-12-22 | ORL @ GSW | L | 14.5 | 2 | 5 | 0 | 2 | 1 | 1 | 0 | 3 | 0.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | -16.0 |
| 2025-12-20 | ORL @ UTA | W | 15.6 | 5 | 4 | 2 | 1 | 2 | 0 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | 2.0 |
| 2025-12-18 | ORL @ DEN | L | 19.4 | 6 | 4 | 1 | 2 | 2 | 0 | 3 | 7 | 42.9% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -18.0 |
| 2025-12-13 | ORL @ NYK | L | 12.6 | 0 | 3 | 1 | 1 | 1 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -15.0 |
| 2025-12-09 | ORL vs. MIA | W | 17.1 | 7 | 6 | 1 | 0 | 2 | 2 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 1 | 1 | 100.0% | 11.0 |
| 2025-12-07 | ORL @ NYK | L | 12.5 | 2 | 3 | 0 | 0 | 1 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -9.0 |
| 2025-12-05 | ORL vs. MIA | W | 20.5 | 8 | 8 | 1 | 0 | 1 | 0 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 11.0 |
| 2025-12-03 | ORL vs. SAS | L | 19.4 | 8 | 5 | 2 | 1 | 1 | 2 | 4 | 4 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 10.0 |
| 2025-12-01 | ORL vs. CHI | W | 17.7 | 8 | 5 | 3 | 1 | 4 | 1 | 3 | 5 | 60.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 6.0 |
| 2025-11-28 | ORL @ DET | W | 14.3 | 4 | 3 | 0 | 1 | 1 | 0 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2025-11-25 | ORL @ PHI | W | 19.6 | 10 | 9 | 2 | 1 | 1 | 1 | 5 | 9 | 55.6% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 11.0 |
| 2025-11-22 | ORL vs. NYK | W | 19.1 | 6 | 7 | 3 | 1 | 1 | 1 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 6.0 |
| 2025-11-20 | ORL vs. LAC | W | 16.3 | 10 | 6 | 3 | 2 | 0 | 1 | 3 | 3 | 100.0% | 0 | 0 | 0.0% | 4 | 4 | 100.0% | 15.0 |
| 2025-11-18 | ORL vs. GSW | W | 13.9 | 6 | 2 | 3 | 1 | 1 | 1 | 3 | 3 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 8.0 |
| 2025-11-16 | ORL @ HOU | L | 15.6 | 4 | 4 | 1 | 1 | 1 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 2 | 4 | 50.0% | -7.0 |
| 2025-11-14 | ORL vs. BKN | W | 16.3 | 6 | 8 | 0 | 0 | 2 | 2 | 3 | 4 | 75.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -4.0 |
| 2025-11-12 | ORL @ NYK | W | 16.3 | 10 | 3 | 0 | 1 | 0 | 1 | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 6 | 6 | 100.0% | 23.0 |
| 2025-11-10 | ORL vs. POR | W | 17.8 | 7 | 5 | 1 | 1 | 2 | 0 | 1 | 3 | 33.3% | 0 | 1 | 0.0% | 5 | 5 | 100.0% | 3.0 |
| 2025-11-09 | ORL vs. BOS | L | 14.9 | 2 | 2 | 1 | 1 | 3 | 0 | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -6.0 |
| 2025-11-07 | ORL vs. BOS | W | 15.4 | 0 | 7 | 1 | 0 | 2 | 1 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 2 | 0.0% | 2.0 |
| 2025-11-04 | ORL @ ATL | L | 12.9 | 4 | 2 | 2 | 0 | 0 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 2 | 2 | 100.0% | 0.0 |
| 2025-11-01 | ORL @ WAS | W | 20.0 | 15 | 6 | 0 | 1 | 3 | 0 | 7 | 8 | 87.5% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 5.0 |
| 2025-10-30 | ORL @ CHA | W | 13.3 | 6 | 3 | 0 | 0 | 1 | 0 | 2 | 4 | 50.0% | 1 | 1 | 100.0% | 1 | 1 | 100.0% | 7.0 |
| 2025-10-29 | ORL @ DET | L | 26.5 | 10 | 6 | 2 | 0 | 1 | 0 | 5 | 5 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -12.0 |
| 2025-10-27 | ORL @ PHI | L | 14.1 | 5 | 3 | 2 | 1 | 0 | 2 | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 1 | 4 | 25.0% | 7.0 |
| 2025-10-25 | ORL vs. CHI | L | 17.0 | 3 | 9 | 2 | 0 | 0 | 1 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 1 | 2 | 50.0% | -18.0 |
| 2025-10-24 | ORL vs. ATL | L | 16.9 | 3 | 5 | 0 | 0 | 2 | 0 | 1 | 3 | 33.3% | 0 | 1 | 0.0% | 1 | 1 | 100.0% | 6.0 |
| 2025-10-22 | ORL vs. MIA | W | 18.5 | 8 | 8 | 4 | 1 | 1 | 0 | 3 | 4 | 75.0% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | 11.0 |